Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA, ex rel., vs. Fresenius Medical
Case Number:
1:05-cv-00227
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 03, 2012
DaVita Inks $55 Million Settlement In Epogen FCA Suit
Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.'s anemia drug Epogen.
-
May 11, 2011
Judge Snips DaVita Kickback Claims In FCA Suit
A Texas federal judge ruled Monday that a former Amgen Inc. employee failed to fully support claims in a qui tam False Claims Act suit accusing dialysis provider DaVita Inc. of receiving kickbacks in the form of educational grants from the drugmaker.